Terms: = Colorectal cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
91 results:
1. Chemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nanoparticles.
Zheng C; Zhang W; Gong X; Xiong F; Jiang L; Zhou L; Zhang Y; Zhu HH; Wang H; Li Y; Zhang P
Sci Adv; 2024 Jun; 10(23):eadk9996. PubMed ID: 38838152
[TBL] [Abstract] [Full Text] [Related]
2. Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer.
Yang L; Yi J; He W; Kong P; Xie Q; Jin Y; Xiong Z; Xia L
Br J Cancer; 2024 Jul; 131(2):334-346. PubMed ID: 38796599
[TBL] [Abstract] [Full Text] [Related]
3. liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon cancer.
Wang P; Zhong W; Huang Q; Zhu Y; Chen L; Ye K
ACS Biomater Sci Eng; 2024 May; 10(5):3136-3147. PubMed ID: 38663028
[TBL] [Abstract] [Full Text] [Related]
4. Mitochondria-Modulating liposomes Reverse Radio-Resistance for colorectal cancer.
Li J; Wang Y; Shen W; Zhang Z; Su Z; Guo X; Pei P; Hu L; Liu T; Yang K; Guo L
Adv Sci (Weinh); 2024 May; 11(18):e2400845. PubMed ID: 38520732
[TBL] [Abstract] [Full Text] [Related]
5. Pooled CRISPR Screening Identifies P-Bodies as Repressors of cancer Epithelial-Mesenchymal Transition.
Fang L; Zhang L; Wang M; He Y; Yang J; Huang Z; Tan Y; Fang K; Li J; Sun Z; Li Y; Tang Y; Liang W; Cui H; Zhu Q; Wu Z; Li Y; Hu Y; Chen W
Cancer Res; 2024 Mar; 84(5):659-674. PubMed ID: 38190710
[TBL] [Abstract] [Full Text] [Related]
6. Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors.
Wang D; Nakayama M; Hong CP; Oshima H; Oshima M
Cancer Res; 2024 Jan; 84(1):56-68. PubMed ID: 37851521
[TBL] [Abstract] [Full Text] [Related]
7. CCDC144NL-AS1/hsa-miR-143-3p/hmga2 interaction: In-silico and clinically implicated in CRC progression, correlated to tumor stage and size in case-controlled study; step toward ncRNA precision.
Abd El Fattah YK; Abulsoud AI; AbdelHamid SG; AbdelHalim S; Hamdy NM
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126739. PubMed ID: 37690651
[TBL] [Abstract] [Full Text] [Related]
8. Peficitinib ameliorates 5-fluorouracil-induced intestinal damage by inhibiting aging, inflammatory factors and oxidative stress.
He S; Xia J; Jia H; Dai Q; Chen C; Zhou Y; Wang XB
Int Immunopharmacol; 2023 Oct; 123():110753. PubMed ID: 37572505
[TBL] [Abstract] [Full Text] [Related]
9. TGM2, hmga2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
Cheraghi-Shavi T; Jalal R; Minuchehr Z
PLoS One; 2023; 18(8):e0289535. PubMed ID: 37535601
[TBL] [Abstract] [Full Text] [Related]
10. Lactoferrin-Modified Gambogic Acid liposomes for colorectal cancer Treatment.
Wang R; Qu J; Tang X; Zhang J; Ou A; Li Q; Chen G; Zheng C; Muhitdinov B; Huang Y
Mol Pharm; 2023 Aug; 20(8):3925-3936. PubMed ID: 37505210
[TBL] [Abstract] [Full Text] [Related]
11. LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells.
Dianat-Moghadam H; Abbasspour-Ravasjani S; Hamishehkar H; Rahbarghazi R; Nouri M
Med Oncol; 2023 Apr; 40(6):156. PubMed ID: 37093287
[TBL] [Abstract] [Full Text] [Related]
12. Investigation of radiomics and deep convolutional neural networks approaches for glioma grading.
Aouadi S; Torfeh T; Arunachalam Y; Paloor S; Riyas M; Hammoud R; Al-Hammadi N
Biomed Phys Eng Express; 2023 Mar; 9(3):. PubMed ID: 36898146
[No Abstract] [Full Text] [Related]
13. Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study.
Qi LN; Ma L; Wu FX; Chen YY; Xu JX; Peng YC; Chen ZS; Gong WF; Yang CL; Wei HW; Qin SL; Shang JJ; Wang QY; Yu HP; Peng T; Huang YW; Ling YC; Tang WZ; Xiang BD; Li LQ
Liver Int; 2022 Oct; 42(10):2283-2298. PubMed ID: 35810457
[TBL] [Abstract] [Full Text] [Related]
14. TP53 Codon 72 Polymorphism and the Risk of colorectal cancer in an Azerbaijani Population.
Yagublu V; Bayramov B; Yuce M; Aslanov H
Turk J Gastroenterol; 2022 Jun; 33(6):485-490. PubMed ID: 35786616
[TBL] [Abstract] [Full Text] [Related]
15. Circle RNA circ_0007331 promotes colorectal carcinoma by targeting miR-205-5p/high-mobility group A2 axis.
Wang L; Weng W; Yang S; Yang S; Du R
Bioengineered; 2022 Apr; 13(4):9312-9321. PubMed ID: 35400282
[TBL] [Abstract] [Full Text] [Related]
16. hmga2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment.
Wang X; Wang J; Zhao J; Wang H; Chen J; Wu J
Theranostics; 2022; 12(2):963-975. PubMed ID: 34976223
[No Abstract] [Full Text] [Related]
17. Prognostic significance of high mobility group A2 (hmga2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic hmga2 expression.
Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528
[TBL] [Abstract] [Full Text] [Related]
18.
Gao X; Wang X
Nucleosides Nucleotides Nucleic Acids; 2021; 40(8):821-828. PubMed ID: 34284697
[TBL] [Abstract] [Full Text] [Related]
19. Multiple myeloma driving factor WHSC1 is a transcription target of oncogene hmga2 that facilitates colon cancer proliferation and metastasis.
Liu HH; Lee CH; Hsieh YC; Hsu DW; Cho EC
Biochem Biophys Res Commun; 2021 Aug; 567():183-189. PubMed ID: 34166916
[TBL] [Abstract] [Full Text] [Related]
20. A KLF4/PiHL/EZH2/hmga2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer.
Deng X; Kong F; Li S; Jiang H; Dong L; Xu X; Zhang X; Yuan H; Xu Y; Chu Y; Peng H; Guan M
Cell Death Dis; 2021 May; 12(5):485. PubMed ID: 33986248
[TBL] [Abstract] [Full Text] [Related]
[Next]
